Gentian Diagnostics ASA (FRA:6FK)
4.960
-0.030 (-0.60%)
At close: Jan 30, 2026
31.91% (1Y)
| Market Cap | 78.40M +46.7% |
| Revenue (ttm) | 14.72M +17.4% |
| Net Income | 3.65M +1,826.9% |
| EPS | 0.23 +1,810.5% |
| Shares Out | n/a |
| PE Ratio | 21.48 |
| Forward PE | 55.91 |
| Dividend | 0.03 (0.70%) |
| Ex-Dividend Date | May 7, 2025 |
| Volume | n/a |
| Average Volume | 1 |
| Open | 4.960 |
| Previous Close | 4.990 |
| Day's Range | 4.960 - 4.960 |
| 52-Week Range | 3.290 - 5.420 |
| Beta | n/a |
| RSI | 56.56 |
| Earnings Date | Feb 11, 2026 |